167 related articles for article (PubMed ID: 37895928)
21. Photocaging of Pyridinylimidazole-Based Covalent JNK3 Inhibitors Affords Spatiotemporal Control of the Binding Affinity in Live Cells.
Hoffelner BS; Andreev S; Plank N; Koch P
Pharmaceuticals (Basel); 2023 Feb; 16(2):. PubMed ID: 37259409
[TBL] [Abstract][Full Text] [Related]
22. Novel Tryptanthrin Derivatives with Selectivity as
Schepetkin IA; Karpenko OS; Kovrizhina AR; Kirpotina LN; Khlebnikov AI; Chekal SI; Radudik AV; Shybinska MO; Quinn MT
Molecules; 2023 Jun; 28(12):. PubMed ID: 37375361
[TBL] [Abstract][Full Text] [Related]
23. Identification of novel serotonin reuptake inhibitors targeting central and allosteric binding sites: A virtual screening and molecular dynamics simulations study.
Erol I; Aksoydan B; Kantarcioglu I; Salmas RE; Durdagi S
J Mol Graph Model; 2017 Jun; 74():193-202. PubMed ID: 28499269
[TBL] [Abstract][Full Text] [Related]
24. Identification of novel PI3Kδ inhibitors by docking, ADMET prediction and molecular dynamics simulations.
Liu YY; Feng XY; Jia WQ; Jing Z; Xu WR; Cheng XC
Comput Biol Chem; 2019 Feb; 78():190-204. PubMed ID: 30557817
[TBL] [Abstract][Full Text] [Related]
25. Discovery of 3-alkyl-5-aryl-1-pyrimidyl-1
Oh Y; Jang M; Cho H; Yang S; Im D; Moon H; Hah JM
J Enzyme Inhib Med Chem; 2020 Dec; 35(1):372-376. PubMed ID: 31856610
[TBL] [Abstract][Full Text] [Related]
26. Targeting the NF-κB/IκBα complex via fragment-based E-Pharmacophore virtual screening and binary QSAR models.
Kanan T; Kanan D; Erol I; Yazdi S; Stein M; Durdagi S
J Mol Graph Model; 2019 Jan; 86():264-277. PubMed ID: 30415122
[TBL] [Abstract][Full Text] [Related]
27. Targeting PDE4A for therapeutic potential: exploiting drug repurposing approach through virtual screening and molecular dynamics.
Shamsi A; Khan MS; Altwaijry N; Hassan N; Shahwan M; Yadav DK
J Biomol Struct Dyn; 2024 Jan; ():1-13. PubMed ID: 38287492
[TBL] [Abstract][Full Text] [Related]
28. Rational modification, synthesis and biological evaluation of 3,4-dihydroquinoxalin-2(1H)-one derivatives as potent and selective c-Jun N-terminal kinase 3 (JNK3) inhibitors.
Dou X; Huang H; Jiang L; Zhu G; Jin H; Jiao N; Zhang L; Liu Z; Zhang L
Eur J Med Chem; 2020 Sep; 201():112445. PubMed ID: 32603981
[TBL] [Abstract][Full Text] [Related]
29. Pyridopyrimidinone Derivatives as Potent and Selective c-Jun N-Terminal Kinase (JNK) Inhibitors.
Zheng K; Park CM; Iqbal S; Hernandez P; Park H; LoGrasso PV; Feng Y
ACS Med Chem Lett; 2015 Apr; 6(4):413-8. PubMed ID: 25893042
[TBL] [Abstract][Full Text] [Related]
30. Discovery of novel selective PI3Kγ inhibitors through combining machine learning-based virtual screening with multiple protein structures and bio-evaluation.
Zhu J; Li K; Xu L; Cai Y; Chen Y; Zhao X; Li H; Huang G; Jin J
J Adv Res; 2022 Feb; 36():1-13. PubMed ID: 35127160
[TBL] [Abstract][Full Text] [Related]
31. Suppression of LPS-Induced Inflammation and Cell Migration by Azelastine through Inhibition of JNK/NF-κB Pathway in BV2 Microglial Cells.
Nguyen PL; Bui BP; Duong MTH; Lee K; Ahn HC; Cho J
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445767
[TBL] [Abstract][Full Text] [Related]
32. High-throughput virtual screening of potential inhibitors of GPR52 using docking and biased sampling method for Huntington's disease therapy.
Gupta H; Sahi S
Mol Divers; 2023 Dec; ():. PubMed ID: 38038795
[TBL] [Abstract][Full Text] [Related]
33. Virtual screening, pharmacokinetics, molecular dynamics and binding free energy analysis for small natural molecules against cyclin-dependent kinase 5 for Alzheimer's disease.
Shukla R; Singh TR
J Biomol Struct Dyn; 2020 Jan; 38(1):248-262. PubMed ID: 30688165
[TBL] [Abstract][Full Text] [Related]
34. Metadynamics as a Postprocessing Method for Virtual Screening with Application to the Pseudokinase Domain of JAK2.
Cutrona KJ; Newton AS; Krimmer SG; Tirado-Rives J; Jorgensen WL
J Chem Inf Model; 2020 Sep; 60(9):4403-4415. PubMed ID: 32383599
[TBL] [Abstract][Full Text] [Related]
35. Virtual screening of small molecules databases for discovery of novel PARP-1 inhibitors: combination of in silico and in vitro studies.
Ekhteiari Salmas R; Unlu A; Bektaş M; Yurtsever M; Mestanoglu M; Durdagi S
J Biomol Struct Dyn; 2017 Jul; 35(9):1899-1915. PubMed ID: 27315035
[TBL] [Abstract][Full Text] [Related]
36. Novel and Potential Small Molecule Scaffolds as DYRK1A Inhibitors by Integrated Molecular Docking-Based Virtual Screening and Dynamics Simulation Study.
Shahroz MM; Sharma HK; Altamimi ASA; Alamri MA; Ali A; Ali A; Alqahtani S; Altharawi A; Alabbas AB; Alossaimi MA; Riadi Y; Firoz A; Afzal O
Molecules; 2022 Feb; 27(4):. PubMed ID: 35208955
[TBL] [Abstract][Full Text] [Related]
37. Computer-aided identification of lead compounds as Staphylococcal epidermidis FtsZ inhibitors using molecular docking, virtual screening, DFT analysis, and molecular dynamic simulation.
Tripathy S; Sahu SK; Azam MA; Jupudi S
J Mol Model; 2019 Nov; 25(12):360. PubMed ID: 31773394
[TBL] [Abstract][Full Text] [Related]
38. Identification of Novel Covalent XPO1 Inhibitors Based on a Hybrid Virtual Screening Strategy.
Shen Z; Zhuang W; Li K; Guo Y; Qu B; Chen S; Gao J; Liu J; Xu L; Dong X; Che J; Li Q
Molecules; 2022 Apr; 27(8):. PubMed ID: 35458742
[TBL] [Abstract][Full Text] [Related]
39. Virtual Screening and Biological Activity Evaluation of New Potent Inhibitors Targeting LRRK2 Kinase Domain.
Tan S; Gong X; Liu H; Yao X
ACS Chem Neurosci; 2021 Sep; 12(17):3214-3224. PubMed ID: 34387082
[TBL] [Abstract][Full Text] [Related]
40. DENVIS: Scalable and High-Throughput Virtual Screening Using Graph Neural Networks with Atomic and Surface Protein Pocket Features.
Krasoulis A; Antonopoulos N; Pitsikalis V; Theodorakis S
J Chem Inf Model; 2022 Oct; 62(19):4642-4659. PubMed ID: 36154119
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
